BLTE Stock Price
$48.95 (+1.00%)
At 2024-05-30 20:00:00 ESTBelite Bio, Inc
(NASDAQ:BLTE) 
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California.
Website: https://belitebio.com/
Founded: 2016
IPO Price: $6 (Apr 29, 2022)
CEO / Founder: Dr. Tom Lin
Sector: Technology
Industry: General
Share this website to your friends
BLTE - Daily
Date: 2024-05-31, O: 48.93, H: 48.95, L: 47.67, C: 48.95, Volume: 19,495
10EMA: 46.3820EMA: 44.6450EMA: 42.85100EMA: 42.69200EMA: 42.71
10EMA: 46.3820EMA: 44.6450EMA: 42.85100EMA: 42.69200EMA: 42.71
NASDAQ:BLTE Stock Key Statistics
| Basic Info: | |||
| Market Cap: | 1.25B | Exchange: | NASDAQ |
| Shares Outstanding: | 29,754,100 | Number of Employees: | |
| Advanced Info: | |||
| Beta: | Return on Equity (ROE) ttm: | -47.90% | |
| Return on Assets (ROA) ttm: | -28.50% | Earnings per Share (EPS) ttm: | -1.19 |
| Book value per Share: | 3.10 | Cash per Share: | 3.18 |
| Current ast per Share: | 3.25 | ||
| Key Ratios: | |||
| P/E ttm: | P/E forward: | ||
| P/E ttm high: | P/E ttm low: | ||
| P/S ttm: | P/B ttm: | 13.78 | |
| P/FCF ttm: | -215.6 | PEG ratio: | |
| Cash Ratios: | |||
| Cash Ratio ttm: | 24.27 | Quick Ratio ttm: | 24.5 |
| Current Ratio ttm: | 24.76 | ||
| Margins: | |||
| Gross Margin ttm: | EBITDA Margin ttm: | ||
| Operating Margin ttm: | Net Income Margin ttm: | ||
| Dividends: | |||
| Trailing Dividend yield: | Forward Dividend yield: | ||
| Payout Ratio ttm: | Ex-Dividend date: | None | |
| Target Prices: | |||
| Target Price High: | Target Price Low: | ||
| Target Price Mean: | Number of Analysts: | ||
| Debt: | |||
| Debt Ratio ttm: | 0.01 | Debt to Equity ttm: | 0.01 |
| Total Net Debt: | -87.27M | ||
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.